XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th Profit Margin

XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th's profit margin stands at 64.89% as of March 2026. That compares with -7.82% in the prior-year period — up 929.3% year over year. That is above the Healthcare sector average of 13.45%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th reported 64.89% in profit margin versus -7.82% a year earlier — a 929.3% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th sits higher the Healthcare benchmark (13.45%) with a profit margin of 64.89%. That is roughly 382.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 64.89% for XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th's profit margin evolved across reporting periods, while the comparison chart places XOMAO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.